• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

描述与 10 种遗传性神经发育障碍相关的神经发育表型:范围综述。

Description of neurodevelopmental phenotypes associated with 10 genetic neurodevelopmental disorders: A scoping review.

机构信息

Cumming School of Medicine, University of Calgary, Calgary, Canada.

Department of Medical Genetics, University of Calgary, Calgary, Canada.

出版信息

Clin Genet. 2021 Mar;99(3):335-346. doi: 10.1111/cge.13882. Epub 2020 Nov 18.

DOI:10.1111/cge.13882
PMID:33179249
Abstract

Neurodevelopmental disorders (NDDs) are a heterogeneous group of conditions including intellectual disability, global developmental delay, autism spectrum disorder, and attention deficit hyperactivity disorder. Advances in genetic diagnostic technology have led to the identification of a number of NDD-associated genes, but reports of cognitive and developmental outcomes in affected individuals have been variable. The objective of this scoping review is to synthesize available information pertaining to the developmental outcomes of individuals with pathogenic variants in ten emerging recurrent NDD-associated genes identified from large scale sequencing studies; ADNP, ANKRD11, ARID1B, CHD2, CHD8, CTNNB1, DDX3X, DYRK1A, SCN2A, and SYNGAP1. After a comprehensive search, 260 articles were selected that reported on neurodevelopmental measures or diagnoses. We identify the spectrum of developmental outcomes for each genetic NDD, including prevalence of intellectual disability, frequency of co-morbid NDDs such as ADHD and autism, and commonly reported medical issues that can help inform diagnosis and treatment. There are significant gaps in our understanding of the natural history of these conditions. Future research focusing on barriers to assessment, the development of modified assessment tools appropriate for long-term outcomes in genetic NDD, and collection of longitudinal data will increase understanding of prognosis in these conditions and inform evaluations of treatment.

摘要

神经发育障碍 (NDD) 是一组异质性疾病,包括智力障碍、全面发育迟缓、自闭症谱系障碍和注意缺陷多动障碍。遗传诊断技术的进步已经导致了许多与 NDD 相关的基因的鉴定,但受影响个体的认知和发育结果的报告存在差异。本范围综述的目的是综合与从大规模测序研究中确定的十个新兴的常染色体显性遗传 NDD 相关基因(ADNP、ANKRD11、ARID1B、CHD2、CHD8、CTNNB1、DDX3X、DYRK1A、SCN2A 和 SYNGAP1)中存在致病性变异的个体的发育结果相关的可用信息。经过全面搜索,选择了 260 篇报告神经发育测量或诊断的文章。我们确定了每个遗传 NDD 的发育结果范围,包括智力障碍的患病率、ADHD 和自闭症等共患 NDD 的频率,以及常见的报告医疗问题,这些问题有助于提供诊断和治疗信息。我们对这些疾病的自然史的了解还存在很大差距。未来的研究应侧重于评估障碍、为遗传 NDD 的长期结果开发适当的改良评估工具,以及收集纵向数据,以提高对这些疾病预后的理解,并为治疗评估提供信息。

相似文献

1
Description of neurodevelopmental phenotypes associated with 10 genetic neurodevelopmental disorders: A scoping review.描述与 10 种遗传性神经发育障碍相关的神经发育表型:范围综述。
Clin Genet. 2021 Mar;99(3):335-346. doi: 10.1111/cge.13882. Epub 2020 Nov 18.
2
Shared and divergent mental health characteristics of ADNP-, CHD8- and DYRK1A-related neurodevelopmental conditions.ADNP、CHD8 和 DYRK1A 相关神经发育障碍的共享和不同的心理健康特征。
J Neurodev Disord. 2024 Apr 15;16(1):15. doi: 10.1186/s11689-024-09532-1.
3
Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders.扩展 PURA 相关神经发育障碍的临床表型和遗传谱。
Brain Dev. 2021 Oct;43(9):912-918. doi: 10.1016/j.braindev.2021.05.009. Epub 2021 Jun 8.
4
Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders.与神经发育障碍相关的物种保守性 SYNGAP1 表型。
Mol Cell Neurosci. 2018 Sep;91:140-150. doi: 10.1016/j.mcn.2018.03.008. Epub 2018 Mar 24.
5
Commonalities and distinctions between two neurodevelopmental disorder subtypes associated with SCN2A and SCN8A variants and literature review.与 SCN2A 和 SCN8A 变异相关的两种神经发育障碍亚型的共同特征和区别及文献复习。
Mol Genet Genomic Med. 2022 May;10(5):e1911. doi: 10.1002/mgg3.1911. Epub 2022 Mar 29.
6
Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.荟萃分析和多学科共识声明:外显子组测序是神经发育障碍个体的一线临床诊断测试。
Genet Med. 2019 Nov;21(11):2413-2421. doi: 10.1038/s41436-019-0554-6. Epub 2019 Jun 11.
7
Phenotypic and genetic analysis of children with unexplained neurodevelopmental delay and neurodevelopmental comorbidities in a Chinese cohort using trio-based whole-exome sequencing.采用基于三亲的全外显子组测序对中国队列中不明原因神经发育迟缓及神经发育合并症患儿进行表型和遗传学分析。
Orphanet J Rare Dis. 2024 May 19;19(1):205. doi: 10.1186/s13023-024-03214-w.
8
Whole Exome Sequencing and Panel-Based Analysis in 176 Spanish Children with Neurodevelopmental Disorders: Focus on Autism Spectrum Disorder and/or Intellectual Disability/Global Developmental Delay.176 名西班牙神经发育障碍儿童的全外显子组测序和基于面板的分析:重点是自闭症谱系障碍和/或智力残疾/全面发育迟缓。
Genes (Basel). 2024 Oct 11;15(10):1310. doi: 10.3390/genes15101310.
9
Progress in Understanding and Treating SCN2A-Mediated Disorders.理解和治疗 SCN2A 介导疾病的进展。
Trends Neurosci. 2018 Jul;41(7):442-456. doi: 10.1016/j.tins.2018.03.011. Epub 2018 Apr 23.
10
Motor phenotypes associated with genetic neurodevelopmental disorders.与遗传性神经发育障碍相关的运动表型。
Ann Clin Transl Neurol. 2024 Dec;11(12):3238-3245. doi: 10.1002/acn3.52231. Epub 2024 Nov 2.

引用本文的文献

1
Vertigo and dizziness in genetic neurodevelopmental disorders: an international cross-sectional study.遗传性神经发育障碍中的眩晕和头晕:一项国际横断面研究。
J Neurol. 2025 Jul 8;272(8):494. doi: 10.1007/s00415-025-13237-3.
2
Environmental adversity, endoplasmic reticulum stress, and neurogenesis.环境逆境、内质网应激与神经发生。
Neurotoxicology. 2025 Jul;109:32-45. doi: 10.1016/j.neuro.2025.05.010. Epub 2025 May 31.
3
Ras, RhoA, and vascular pharmacology in neurodevelopment and aging.Ras、RhoA与神经发育和衰老中的血管药理学
Neurochem Int. 2024 Dec;181:105883. doi: 10.1016/j.neuint.2024.105883. Epub 2024 Oct 18.
4
Exploring the origins of neurodevelopmental proteasomopathies associated with cardiac malformations: are neural crest cells central to certain pathological mechanisms?探索与心脏畸形相关的神经发育蛋白酶体病的起源:神经嵴细胞在某些病理机制中起核心作用吗?
Front Cell Dev Biol. 2024 Jul 12;12:1370905. doi: 10.3389/fcell.2024.1370905. eCollection 2024.
5
Mechanisms of neurodevelopmental toxicity of topiramate.托吡酯的神经发育毒性机制。
Crit Rev Toxicol. 2024 Aug;54(7):465-475. doi: 10.1080/10408444.2024.2368552. Epub 2024 Jul 12.
6
Shared and divergent mental health characteristics of ADNP-, CHD8- and DYRK1A-related neurodevelopmental conditions.ADNP、CHD8 和 DYRK1A 相关神经发育障碍的共享和不同的心理健康特征。
J Neurodev Disord. 2024 Apr 15;16(1):15. doi: 10.1186/s11689-024-09532-1.
7
Consensus reporting guidelines to address gaps in descriptions of ultra-rare genetic conditions.解决超罕见遗传病描述中差距的共识报告指南。
NPJ Genom Med. 2024 Apr 6;9(1):27. doi: 10.1038/s41525-024-00408-w.
8
Healthcare utilization and clinical characteristics of genetic epilepsy in electronic health records.电子健康记录中遗传性癫痫的医疗保健利用情况及临床特征
Brain Commun. 2024 Mar 14;6(2):fcae090. doi: 10.1093/braincomms/fcae090. eCollection 2024.
9
GRID1/GluD1 homozygous variants linked to intellectual disability and spastic paraplegia impair mGlu1/5 receptor signaling and excitatory synapses.与智力障碍和痉挛性截瘫相关的GRID1/GluD1纯合变体损害了代谢型谷氨酸受体1/5(mGlu1/5)信号传导和兴奋性突触。
Mol Psychiatry. 2024 Apr;29(4):1205-1215. doi: 10.1038/s41380-024-02469-w. Epub 2024 Feb 28.
10
Clinical phenotypic spectrum of CTNNB1 neurodevelopmental disorder.CTNNB1 神经发育障碍的临床表型谱。
Clin Genet. 2024 May;105(5):523-532. doi: 10.1111/cge.14487. Epub 2024 Jan 21.